CHICAGO -- Cetuximab (Erbitux) added to first-line chemotherapy for metastatic colorectal cancer lengthens progression-free survival by about a month, researchers found.

CHICAGO -- Recurrence rates for resectable liver metastases from colorectal cancer are lower when adjuvant and neoadjuvant chemotherapy augment surgery, researchers said here.

CHICAGO -- Parents of children with cancer gain hope from information about the prognosis, even when the outlook is poor, according to a survey.

CHICAGO -- For infants and children with intermediate-risk neuroblastoma, a milder therapy regimen can preserve good long-term survival and minimize toxicity, found an international trial.

CHICAGO -- Arsenic trioxide (Trisenox) improves survival for acute promyelocytic leukemia when added to first-line treatment, researchers found.

CHICAGO -- Radium-223, an investigational bone-seeking radioisotope, appeared to slow progression of skeletal metastases in hormone-refractory prostate cancer, researchers reported here.

KINGSTON, Ontario -- Using antipsychotic drugs to treat patients with dementia may be fatal, according to researchers here.

ROCHESTER, N.Y. -- Surgery for intractable temporal lobe epilepsy may cause a decline in verbal recall memory in about a third of patients, but the opportunity to end seizures may be worth the risk, investigators here said.

CHICAGO -- Oxaliplatin (Eloxatin)-containing chemotherapy boosts overall survival for stage III colon cancer, with a hint of benefit for high-risk stage II disease as well, according to large randomized trial.

BOSTON -- Suicidal tendencies that arise in some men who start on the antidepressant citalopram (Celexa) may be linked to genetic mutations, investigators in Boston and Dallas reported.

CHICAGO -- Neoadjuvant chemotherapy did not improve survival of patients with resectable non-small cell lung cancer (NSCLC) compared with surgery alone, researchers reported here.

OTTAWA, Ontario -- Men ought to swear off cigarettes long before they even think of having children, according to researchers here.

CHICAGO -- Localized prostate cancer needs a balanced view of treatment options from both urologists and radiologists, researchers said here.

CHICAGO -- For node-positive breast cancer, an abbreviated course of adjuvant radiation with fewer fractions and a lower total dose does not appear to add to the risk of local recurrence, British researchers said here.

CHICAGO -- Two novel therapies targeting vascular endothelial growth factor demonstrated activity in refractory thyroid and ovarian cancer, investigators reported here.

CHICAGO -- Less than a third of the survivors of childhood cancer get routine cancer-related health care as young adults, even though they are likely to have more serious need than others their age, researchers found.

CHICAGO -- Adding shark cartilage extract to chemoradiation failed to improve survival in non-small cell lung cancer (NSCLC) patients, results of a government-mandated clinical study show.

CHICAGO -- Flaxseed supplementation significantly reduced cancer cell proliferation rates in men with prostate cancer, investigators in a multicenter study found.

CHICAGO -- Prophylactic cranial irradiation after chemotherapy significantly reduces the risk of brain metastasis and doubles one-year survival in small-cell lung cancer (SCLC), a Dutch oncologist reported here.

CHICAGO -- Almost all patients treated off-label with dasatinib (Sprycel) for chronic myelogenous leukemia (CML) had a complete cytogenetic response within a year of beginning therapy, researchers reported here.